Literature DB >> 444681

[Successful therapy of chronic myelomonocytic leukemia with vp 16-213 (author's transl)].

L Labedzki, H J Illiger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 444681     DOI： 10.1007/bf01007903

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  9 in total

1.  Monocytic leukemia.

Authors:  C M SINN; F W DICK
Journal:  Am J Med       Date:  1956-04       Impact factor: 4.965

2.  Comparison of the biologic activity of VP-16-213 given iv and orally in capsules or drink ampules.

Authors:  K W Brunner; R W Sonntag; H J Ryssel; F Cavalli
Journal:  Cancer Treat Rep       Date:  1976-09

3.  Annotation: Subacute and chronic myelomonocytic leukaemia: a distinct haematological entity.

Authors:  R Zittoun
Journal:  Br J Haematol       Date:  1976-01       Impact factor: 6.998

4.  Acute monoblastic leukemia: diagnosis and treatment of ten cases.

Authors:  R W McKenna; C D Bloomfield; F Dick; M E Nesbit; R D Brunning
Journal:  Blood       Date:  1975-10       Impact factor: 22.113

5.  Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas.

Authors:  G Mathé; L Schwarzenberg; P Pouillart; R Oldham; R Weiner; C Jasmin; C Rosenfeld; M Hayat; J L Misset; M Musset; M Schneider; J L Amiel; F De Vassal
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

Review 6.  Chronic myelomonocytic leukemia in adults.

Authors:  P A Miescher; J J Farguet
Journal:  Semin Hematol       Date:  1974-04       Impact factor: 3.851

7.  Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors.

Authors:  H Stähelin
Journal:  Eur J Cancer       Date:  1973-03       Impact factor: 9.162

8.  The significance of lysozyme estimations in acute myeloid and chronic monocytic leukaemia.

Authors:  D Catovsky; D A Galton; C Griffin
Journal:  Br J Haematol       Date:  1971-11       Impact factor: 6.998

9.  Lysozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemia.

Authors:  F M Muggia; H O Heinemann; M Farhangi; E F Osserman
Journal:  Am J Med       Date:  1969-09       Impact factor: 4.965
  9 in total
  1 in total

1.  [Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].

Authors:  H J Schmoll; N Niederle; W Achterrath
Journal:  Klin Wochenschr       Date:  1981-11-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.